Dr. Virginia G. Kaklamani
Claim this profileUniversity of Texas Health Science Center at San Antonio
Expert in Breast Cancer
Studies Breast cancer
13 reported clinical trials
46 drugs studied
Area of expertise
1Breast Cancer
Global LeaderHER2 negative
Stage IV
Stage I
2Breast Cancer
HER2 negative
Stage IV
HER2 positive
Affiliated Hospitals
Clinical Trials Virginia G. Kaklamani is currently running
MEN2312
for Breast Cancer
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.
Recruiting1 award Phase 12 criteria
Elacestrant
for Breast Cancer
The purpose of this study is to evaluate the efficacy and safety of elacestrant over the course of 6 months in patients with estrogen receptor positive (ER+)/human epidermal growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-dependent kinase targeting enzymes CDK4 and CDK6 inhibitor (CDK4/6i) in the metastatic setting.
Recruiting1 award Phase 217 criteria
More about Virginia G. Kaklamani
Clinical Trial Related7 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Virginia G. Kaklamani has experience with
- Abemaciclib
- Cyclosporin A
- Elacestrant
- Positron Emission Tomography
- Computed Tomography
- Fludeoxyglucose F-18
Breakdown of trials Virginia G. Kaklamani has run
Breast Cancer
Breast cancer
Skin Cancer
Cancer
DNA Damage Repair Deficiency
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Virginia G. Kaklamani specialize in?
Virginia G. Kaklamani focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are Stage IV.
Is Virginia G. Kaklamani currently recruiting for clinical trials?
Yes, Virginia G. Kaklamani is currently recruiting for 6 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Virginia G. Kaklamani has studied deeply?
Yes, Virginia G. Kaklamani has studied treatments such as Abemaciclib, Cyclosporin A, Elacestrant.
What is the best way to schedule an appointment with Virginia G. Kaklamani?
Apply for one of the trials that Virginia G. Kaklamani is conducting.
What is the office address of Virginia G. Kaklamani?
The office of Virginia G. Kaklamani is located at: University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229 United States. This is the address for their practice at the University of Texas Health Science Center at San Antonio.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.